» Articles » PMID: 28410410

Diabetes Mellitus in Patients with Chronic Obstructive Pulmonary Disease-The Impact on Mortality

Overview
Journal PLoS One
Date 2017 Apr 15
PMID 28410410
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. There is evidence to support a connection between COPD and diabetes mellitus (DM), another common medical disorder. However, additional research is required to improve our knowledge of these relationships and their possible implications. In this study, we investigated the impact of DM on patient outcomes through the clinical course of COPD.

Methods: We conducted a cohort study in patients from the Taiwan Longitudinal Health Insurance Database between 2000 and 2013. Patients with COPD were identified and assessed for pre-existing and incident DM. A Cox proportional hazards model was built to identify factors associated with incident DM and to explore the prognostic effects of DM on COPD patients. A propensity score method was used to match COPD patients with incident DM to controls without incident DM.

Results: Pre-existing DM was present in 332 (16%) of 2015 COPD patients who had a significantly higher hazard ratio (HR) [1.244, 95% confidence interval (CI) 1.010-1.532] for mortality than that of the COPD patients without pre-existing DM. During the 10-year follow-up period, 304 (19%) of 1568 COPD patients developed incident DM; comorbid hypertension (HR, 1.810; 95% CI, 1.363-2.403), cerebrovascular disease (HR, 1.517; 95% CI, 1.146-2.008) and coronary artery disease (HR, 1.408; 95% CI 1.089-1.820) were significant factors associated with incident DM. Survival was worse for the COPD patients with incident DM than for the matched controls without incident DM (Log-rank, p = 0.027).

Conclusions: DM, either pre-existing or incident, was associated with worse outcomes in COPD patients. Targeted surveillance and management of DM may be important in clinical care of the COPD population.

Citing Articles

Bioinformatic Insights and XGBoost Identify Shared Genetics in Chronic Obstructive Pulmonary Disease and Type 2 Diabetes.

Ji Q, Meng Y, Han X, Yi C, Chen X, Zhan Y Clin Respir J. 2025; 19(3):e70057.

PMID: 40045538 PMC: 11882755. DOI: 10.1111/crj.70057.


Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes.

Ray A, Paik J, Wexler D, Sreedhara S, Bykov K, Feldman W JAMA Intern Med. 2025; .

PMID: 39928303 PMC: 11811870. DOI: 10.1001/jamainternmed.2024.7811.


Hyperglycaemia and Chronic Obstructive Pulmonary Disease.

Cazzola M, Rogliani P, Ora J, Calzetta L, Lauro D, Matera M Diagnostics (Basel). 2023; 13(21).

PMID: 37958258 PMC: 10650064. DOI: 10.3390/diagnostics13213362.


Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort.

Mangold V, Boesing M, Berset C, Bridevaux P, Geiser T, Joos Zellweger L J Clin Med. 2023; 12(20).

PMID: 37892775 PMC: 10607923. DOI: 10.3390/jcm12206636.


All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD).

Raslan A, Quint J, Cook S Int J Chron Obstruct Pulmon Dis. 2023; 18:1207-1218.

PMID: 37332839 PMC: 10276568. DOI: 10.2147/COPD.S407085.


References
1.
Lin J, Shau W, Lai M . Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol. 2014; 132(8):922-8. DOI: 10.1001/jamaophthalmol.2014.859. View

2.
Leslie R, Palmer J, Schloot N, Lernmark A . Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia. 2015; 59(1):13-20. DOI: 10.1007/s00125-015-3789-z. View

3.
Ehrlich S, Quesenberry Jr C, Van Den Eeden S, Shan J, Ferrara A . Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2009; 33(1):55-60. PMC: 2797986. DOI: 10.2337/dc09-0880. View

4.
Marhoffer W, Stein M, Maeser E, Federlin K . Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992; 15(2):256-60. DOI: 10.2337/diacare.15.2.256. View

5.
Khedr E, El Shinawy O, Khedr T, Abdel aziz ali Y, Awad E . Assessment of corticodiaphragmatic pathway and pulmonary function in acute ischemic stroke patients. Eur J Neurol. 2000; 7(5):509-16. DOI: 10.1046/j.1468-1331.2000.00104.x. View